HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Ramirez Selected Research

S-allylcysteine (allyl cysteine)

11/2017Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Ramirez Research Topics

Disease

2Inflammation (Inflammations)
11/2017 - 06/2013
1Multiple Sclerosis
11/2017
1Paralysis (Palsy)
11/2017
1Dysbiosis
11/2017
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2017
1Periodontal Diseases (Periodontal Disease)
06/2013
1Periodontitis
06/2013
1Necrosis
06/2013
1Pre-Eclampsia (Preeclampsia)
06/2013
1Bluetongue
07/2004

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
11/2017 - 06/2013
1lipopolysaccharide-binding proteinIBA
11/2017
1S-allylcysteine (allyl cysteine)IBA
11/2017
1Glutathione (Reduced Glutathione)IBA
11/2017
1LipopolysaccharidesIBA
11/2017
1Proteins (Proteins, Gene)FDA Link
11/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2017
1Myelin-Oligodendrocyte GlycoproteinIBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
06/2013
1C-Reactive ProteinIBA
06/2013
1AntibodiesIBA
07/2004